Market closedNon-fractional

Eliem Therapeutics/ELYM

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Eliem Therapeutics

Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Its main drug candidate is ETX-155 for major depressive disorder (MDD) and focal onset seizures (FOS).

Ticker

ELYM

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Wilmington, United States

Employees

10

ELYM Metrics

BasicAdvanced
$458M
Market cap
-
P/E ratio
-$0.53
EPS
-0.33
Beta
-
Dividend rate
$458M
-0.33
37.025
36.289
0.211
-9.09%
-13.01%
1.78
1.78
-25.839
-74.15%
-67.54%

ELYM Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$1.6M
-55.56%
Profit margin
0.00%
NaN%

ELYM Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 20.00%
QuarterlyAnnual
Q2 22
Actual
-$0.56
Expected
-$0.47
Surprise
20.00%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Eliem Therapeutics stock?

Eliem Therapeutics (ELYM) has a market cap of $458M as of July 06, 2024.

What is the P/E ratio for Eliem Therapeutics stock?

The price to earnings (P/E) ratio for Eliem Therapeutics (ELYM) stock is 0 as of July 06, 2024.

Does Eliem Therapeutics stock pay dividends?

No, Eliem Therapeutics (ELYM) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Eliem Therapeutics dividend payment date?

Eliem Therapeutics (ELYM) stock does not pay dividends to its shareholders.

What is the beta indicator for Eliem Therapeutics?

Eliem Therapeutics (ELYM) has a beta rating of -0.33. This means that it has an inverse relation to market volatility.

Buy or sell Eliem Therapeutics stock

Buy or sell Eliem Therapeutics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing